The role of adjuvants in vaccination is to non-specifically enhance and shape the immune response to specific antigenic components of vaccines through targeted activation of the immune system.
is a synthetic vaccine adjuvant which can be simply added to target antigens to improve vaccine response. IC31®
has demonstrated activity in clinical trials supported by a very good safety and tolerability profile. The technology has been licensed to a number of vaccine companies. Further licensing opportunities are available